Found: 9
Select item for more details and to access through your institution.
XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920974201
- By:
- Publication type:
- Article
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00350-5
- By:
- Publication type:
- Article
FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1866, doi. 10.3390/cancers13081866
- By:
- Publication type:
- Article
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00298-0
- By:
- Publication type:
- Article
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers.
- Published in:
- Biomedicines, 2021, v. 9, n. 1, p. 56, doi. 10.3390/biomedicines9010056
- By:
- Publication type:
- Article
From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1345415
- By:
- Publication type:
- Article
Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00524-3
- By:
- Publication type:
- Article
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
- Published in:
- Theranostics, 2021, v. 11, n. 17, p. 8350, doi. 10.7150/thno.51456
- By:
- Publication type:
- Article
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10966, doi. 10.3390/ijms241310966
- By:
- Publication type:
- Article